Older persons with diabetes have a harder time maintaining blood pressure when standing up. When blood pressure drops when standing up, fainting may occur. This study will see how regular exercise can improve the ability of the body to keep blood pressure up when standing. We want to see how this improvement varies with a home-based walking program.
Detailed Summary 1. PURPOSE: Older adults with diabetes faint frequently, due to an impairment in the cardiovascular control mechanisms (arterial baroreceptor function, autonomic nervous system function and cerebral autoregulation) that prevent syncope. The purpose of this study is to examine the ability of a home based walking program to reverse these impairments. 2. HYPOTHESES: a) A home-based walking program will improve the compensatory cardiovascular responses that prevent syncope in older adults with Type 2 diabetes. A moderate, regular exercise program will: * increase arterial baroreflex sensitivity * increase heart rate variability (marker of autonomic nervous system function) * decrease cerebrovascular resistance * improve cerebral autoregulation during upright tilt. b) There will be relationship between the improvement in compensatory cardiovascular responses and regular exercise. c) Design of more practicable training prescriptions than that used in a research setting.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
13
After the completion of the control phase and at the start of the titration phase of the study, participants will be given pedometers and log books, then contacted on a regular basis to help insure compliance with the goal of walking 10,000 steps per day.
VITALiTY Research Centre - VGH Research Pavilion
Vancouver, British Columbia, Canada
Dr. Scott Lear's Lab, Simon Fraser University, Harbour
Vancouver, British Columbia, Canada
Pulse wave velocity (central and peripheral)
Time frame: Measured at Baseline, 3 months after control phase and after 3 months of Intervention phase
Drop in middle cerebral artery velocity with upright tilting
Time frame: Measured at Baseline, 3 months after control phase and after 3 months of Intervention phase
Drop in blood pressure with upright tilt
Time frame: Measured at Baseline, 3 months after control phase and after 3 months of Intervention phase
Arterial baroreflex sensitivity
Time frame: Measured at Baseline, 3 months after control phase and after 3 months of Intervention phase
Fasting blood glucose, HgbA1C
Time frame: Measured at Baseline, 3 month after control phase and after 3 months of Intervention phase.
VO2max
Time frame: Measured at Baseline, 3 month after control phase and after 3 months of Intervention phase.
Dynamometry measures of muscle strength
Time frame: Measured at Baseline, 3 month after control phase and after 3 months of Intervention phase.
Resting and maximal heart rate
Time frame: Measured at Baseline, 3 month after control phase and after 3 months of Intervention phase.
Waist to hip ratio, BMI
Time frame: Measured at Baseline, 3 month after control phase and after 3 months of Intervention phase.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Lean body mass/% fat
Time frame: Measured at Baseline, 3 month after control phase and after 3 months of Intervention phase.
Catecholamines
Time frame: Measured at Baseline, 3 month after control phase and after 3 months of Intervention phase.
Increase in Gosling's pulsatility index
Time frame: Measured at Baseline, 3 month after control phase and after 3 months of Intervention phase.